Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst. 2007 Oct 17; 99(20):1516-24.